Display options
Share it on

Comp Hepatol. 2004 Jan 14;3:S46. doi: 10.1186/1476-5926-2-S1-S46.

Peroxynitrite formation and sinusoidal endothelial cell injury during acetaminophen-induced hepatotoxicity in mice.

Comparative hepatology

Tamara R Knight, Hartmut Jaeschke

Affiliations

  1. Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA. [email protected]

PMID: 14960198 PMCID: PMC2410261 DOI: 10.1186/1476-5926-2-S1-S46

Abstract

INTRODUCTION: Vascular injury and accumulation of red blood cells in the space of Disse (hemorrhage) is a characteristic feature of acetaminophen hepatotoxicity. However, the mechanism of nonparenchymal cell injury is unclear. Therefore, the objective was to investigate if either Kupffer cells or intracellular events in endothelial cells are responsible for the cell damage. RESULTS: Acetaminophen treatment (300 mg/kg) caused vascular nitrotyrosine staining within 1 h. Vascular injury (hemorrhage) occurred between 2 and 4 h. This paralleled the time course of parenchymal cell injury as shown by the increase in plasma alanine aminotransferase activities. Inactivation of Kupffer cells by gadolinium chloride (10 mg/kg) had no significant effect on vascular nitrotyrosine staining, hemorrhage or parenchymal cell injury. In contrast, treatment with allopurinol (100 mg/kg), which prevented mitochondrial injury in hepatocytes, strongly attenuated vascular nitrotyrosine staining and injury. CONCLUSIONS: Our data do not support the hypothesis that acetaminophen-induced superoxide release leading to vascular peroxynitrite formation and endothelial cell injury is caused by activated Kupffer cells. In contrast, the protective effect of allopurinol treatment suggests that, similar to the mechanism in parenchymal cells, mitochondrial oxidant stress and peroxynitrite formation in sinusoidal endothelial cells may be critical for vascular injury after acetaminophen overdose.

References

  1. Arch Biochem Biophys. 1989 Sep;273(2):449-57 - PubMed
  2. Hepatology. 1995 Apr;21(4):1045-50 - PubMed
  3. Eur J Biochem. 1990 Sep 11;192(2):245-61 - PubMed
  4. J Pharmacol Exp Ther. 1973 Oct;187(1):195-202 - PubMed
  5. J Leukoc Biol. 1997 Jun;61(6):647-53 - PubMed
  6. J Leukoc Biol. 1990 Aug;48(2):123-8 - PubMed
  7. J Gastroenterol Hepatol. 2000 Jul;15(7):718-24 - PubMed
  8. Hepatology. 2001 Feb;33(2):397-405 - PubMed
  9. Am J Physiol. 1991 Dec;261(6 Pt 1):G1051-6 - PubMed
  10. Toxicol Sci. 2002 Jan;65(1):135-50 - PubMed
  11. Toxicol Sci. 2001 Aug;62(2):212-20 - PubMed
  12. Pharmacol Ther. 1993 Oct;60(1):91-120 - PubMed
  13. J Pharmacol Exp Ther. 1990 Dec;255 (3):935-41 - PubMed
  14. Toxicol Appl Pharmacol. 1988 May;93(3):378-87 - PubMed
  15. Free Radic Res Commun. 1991;15(5):277-84 - PubMed
  16. Toxicol Appl Pharmacol. 1986 Nov;86(2):204-15 - PubMed
  17. Shock. 1995 Jan;3(1):56-62 - PubMed
  18. Am J Physiol. 1991 Mar;260(3 Pt 1):G355-62 - PubMed
  19. Hepatology. 1993 May;17(5):915-23 - PubMed
  20. Comp Hepatol. 2004 Jan 14;3 Suppl 1:S33 - PubMed
  21. Toxicol Sci. 2000 Apr;54(2):509-16 - PubMed
  22. Hepatology. 1985 Mar-Apr;5(2):233-40 - PubMed
  23. Toxicol Sci. 2002 Jun;67(2):322-8 - PubMed
  24. Toxicol Appl Pharmacol. 2000 Nov 15;169(1):77-83 - PubMed
  25. Biochem Pharmacol. 1997 May 9;53(9):1339-45 - PubMed
  26. Hepatology. 1999 Jul;30(1):186-95 - PubMed
  27. Toxicol Appl Pharmacol. 2002 Jun 1;181(2):133-41 - PubMed
  28. Am J Pathol. 1983 Dec;113(3):321-30 - PubMed
  29. Comp Hepatol. 2003 Jan 3;2(1):1 - PubMed
  30. J Pharmacol Exp Ther. 1973 Oct;187(1):211-7 - PubMed
  31. Cardiovasc Res. 1996 Oct;32(4):752-63 - PubMed
  32. J Pharmacol Exp Ther. 2002 Nov;303(2):468-75 - PubMed
  33. Semin Liver Dis. 1990 Nov;10 (4):267-78 - PubMed

Publication Types